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ABSTRACT The action of three-ﬁnger snake a-neurotoxins at their targets, nicotinic acetylcholine receptors (nAChR), is widely
studied because of its biological and pharmacological relevance. Most such studies deal only with ligands and receptor models;
however, for many ligand/receptor systems the membrane environment may affect ligand binding. In this work we focused on
binding of short-chain a-neurotoxin II (NTII) from Naja oxiana to the native-like lipid bilayer, and the possible role played by
the membrane in delivering the toxin to nAChR. Experimental (NMR and mutagenesis) and molecular modeling (molecular-
dynamics simulation) studies revealed a speciﬁc interaction of the toxin molecule with the phosphatidylserine headgroup of lipids,
resulting in the proper topology of NTII on lipid bilayers favoring the attack of nAChR. Analysis of short-chain a-neurotoxins
showed that most of them possess a high positive charge and sequence homology in the lipid-binding motif of NTII, implying
that interaction with the membrane surrounding nAChR may be common for the toxin family.
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Interactions between ligands and membrane receptors play
a key role in many biological processes. One of the most
intensively studied ligand/receptor systems is that of neuro-
toxins and nicotinic acetylcholine receptors (nAChRs),
which are nonselective cation channels that mediate fast
chemical transmission of electrical signal in the nervous
system (1,2). The pentameric extracellular domain of
nAChR contains ligand-binding sites for agonists (e.g.,
acetylcholine and nicotine) and antagonists (e.g., snake and
cone snail toxins). Snake a-neurotoxins are particularly
interesting because of their different binding kinetics and
the high affinity and selectivity of their interaction with
various types of nAChRs, which are subdivided into two
major classes—neuronal and muscle—depending on their
localization and subunit composition. These toxins are small
and stable proteins that retain their intrinsic ‘‘three-finger’’
b-structural fold upon binding to nAChR (1,3). Short-chain
a-neurotoxins (four disulfide bonds, 60–62 amino acid resi-
dues) selectively inhibit only muscle-type nAChRs, whereas
long-chain a-neurotoxins (five disulfide bonds, 66–75 amino
acid residues) with an additional disulfide bond in the tip of
the central loop (loop II) can inhibit both muscle and
neuronal nAChRs (1,2). Although binding of a-neurotoxins
to nAChR has been extensively investigated with the aid of
site-directed mutagenesis, chemical modifications, NMR,
x-ray, and molecular modeling analyses in various studies
(1,4–7), most of these studies focused on molecular models
of the toxin-receptor complex formation, in which the
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0006-3495/09/10/2089/9 $2.00membrane environment of nAChR was not taken into
consideration.
However, it was found that for many membrane receptors,
the lipid membrane could influence local concentration,
diffusion, conformation, and orientation of a ligand, facili-
tating its recognition by the receptor, i.e., the membrane
could optimize the ligand/receptor interaction through
several different effects via the so-called ‘‘membrane catal-
ysis’’ (also known as the ‘‘membrane-compartment’’) mech-
anism (8,9). In the case of nAChR, it is well known that some
membrane properties (i.e., fluidity, surface charge density,
lipid packing, and composition) affect functioning of the
receptor and can influence its ligand binding (10–16). In
particular, it was proposed that an approach of a-neurotoxins
to their binding sites is sensitive to the physical state of the
plasma membrane surrounding nAChR (13). Thus, the lipid
bilayer may play a certain role in a-neurotoxin inhibition of
nAChR. Notably, mammalian prototoxin lynx1, an endoge-
nous nAChR modulator with the snake toxin-like fold, is
normally presented at the cell surface as a glycophosphatidy-
linositol-anchored protein (17). Furthermore, the recently
determined low-resolution (~14 A˚) x-ray structure of a-bun-
garotoxin (a long-chain a-neurotoxin) in complex with the
membrane-bound Torpedo nAChR revealed direct contacts
between the toxin and the lipid bilayer surrounding the
receptor (18). These facts prompted us to conduct a detailed
investigation of the interaction between a-neurotoxins and
the membrane environment of nAChRs.
In this study we focused on the interaction of neurotoxin II
(NTII), a short-chain a-neurotoxin from Naja oxiana, with
liposomes mimicking the membranes of native Torpedo
nAChR, using the methods of NMR spectroscopy supported
by mutagenesis and molecular modeling. A bacterial expres-
sion system developed for NTII (4) allowed the employment
doi: 10.1016/j.bpj.2009.07.037
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bacterial expression system the complex of 15N/13C-labaled
NTII with nAChR was characterized by solid-state NMR
approach (3). Here we described the NTII membrane-
binding site, which is remote from the receptor inhibition
site and defines the position of a toxin molecule on the
membrane surface in an orientation favoring subsequent
docking to nAChR. Our findings are in agreement with the
‘‘membrane catalysis’’ concept, and indicate that the specific
membrane binding of the toxin can precede receptor recog-
nition, shedding new light on events that may occur during
action of the a-neurotoxins at their targets.
MATERIALS AND METHODS
Bacterial expression, isolation, and puriﬁcation
of recombinant NTII, its mutant, and 15N-labeled
analogs
Recombinant NTII, its mutants, and their 15N-labeled analogs were
produced as previously described (4). The mutations were introduced into
the NTII gene by polymerase chain reaction on the basis of the previously
developed plasmid pET22b/STII/NTII (4). The protocol used for the produc-
tion and purification of uniformly 15N-labeled NTII and mutants was the
same as for the nonlabeled toxins, with the exception that 15NH4Cl was
used as the sole source of nitrogen (15N > 99%; Martek Biosciences,
Columbia, MD). All steps for protein production, isolation, and purification
were controlled by 12% Tris/Tricine sodium dodecyl sulfate polyacrylamide
gel electrophoresis. The purity of the toxins was checked by analytical high-
performance liquid chromatography (Smartline; Knauer, Berlin, Germany),
which revealed the content of impurities as<5%. The N-terminal amino acid
sequence of the obtained proteins was determined using a gas-phase seque-
nator (Protein Sequencer 470A; Applied Biosystems, Foster City, CA).
Recombinant neurotoxins were analyzed by matrix-assisted laser desorp-
tion/ionization mass-spectrometry (Daltonics Ultraflex II TOF/TOF instru-
ment; Bruker Daltonik, Bremen, Germany), circular dichroism (CD, J-810
spectropolarimeter; Jasco, Tokyo, Japan), and NMR spectroscopy.
Liposome preparation
Synthetic membrane components—dioleoylphosphatidylcholine (DOPC),
dioleoylphosphatidylserine (DOPS), and cholesterol (Chol)—were
purchased from Avanti Polar Lipids (Alabaster, AL). A lipid composition
of molar ratio DOPC/DOPS/Chol¼ 3:1:1 was prepared by mixing the phos-
pholipids and cholesterol dissolved in chloroform/methanol (volume ratio
2:1), and evaporation on a SpeedVac vacuum dryer (Savant, Waltham,
Quebec, Canada) followed by overnight drying at high vacuum. Multilamel-
lar bilayer liposomes were prepared by dissolving lipid powders in 10 mM
NaPAc buffer, pH 5.5, containing 5% 2H2O, 1 mM EDTA, and 1.5 mM
KCl. Freeze-thawing and mechanical agitation for 2 h were performed to
facilitate hydration of the lipids. Monolamellar liposomes were prepared
by extruding a multilamellar liposome dispersion through a polycarbonate
filter with a pore size of 1000 A˚ using an Avanti Mini-Extruder. The
recombinant NTII dissolved in the same buffer was added to the liposomes
to obtain the required lipid/toxin ratio. Thermocycling and thorough stirring
were used as described previously (19) to homogenize the samples contain-
ing NTII and liposomes.
Acquisition and analysis of NMR spectra
All NMR experiments were performed on liquid crystalline bilayer
membranes at 303 K. The 31R-NMR spectra were obtained on a DRX-500
spectrometer (Bruker BioSpin, Rheinstetten, Germany) with the aid of
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of 40 ms and repetition time of 3–5 s. Typically, 8192–57344 scans were
acquired. Symmetrical 5 mm/15 mm NMR tubes (Shigemi, Allison Park,
PA) were used. During acquisition, broadband 1H decoupling was applied.
Spectral processing was performed with the TOPSPIN software (Bruker
BioSpin). Theoretical 31P-NMR spectra were calculated and fitted to the
experimental ones using the P-FIT program under the assumption that in a
magnetic field the liposomes will adopt an ellipsoidal shape (20). The adjust-
able parameters of the fit were the chemical shift anisotropies (CSAs), inte-
gral intensities, axis ratio of the ellipsoidal liposomes (c/a), and broadening
function parameters. The 1H WATERGATE (21) and 1H-15N heteronuclear
single quantum coherence (HSQC) (22) spectra for free NTII or NTII/lipo-
some suspension samples were acquired on a Unity-600 spectrometer
(Varian, Palo Alto, CA) using standard 5 mm NMR tubes. 1H-15N HSQC
spectra were detected as previously described (22), with an acquisition
time t2 of 0.1 s, 1600 data points, relaxation delay of 1.9 s, typically 32
scans, and 100 complex t1 increments. Spectral widths were 1800 Hz in
F1 and 8000 Hz in F2. The nitrogen decoupling during acquisition was
achieved through the use of a 1 kHz WALTZ decoupling field as previously
described (22). Assignment of the 1H and 15N resonances of NTII was taken
from Bocharov et al. (23). NMR spectra were analyzed using the VNMR
(Varian, Palo Alto, CA) program. The sensitivity of the NMR probe was
monitored using the 1H-NMR signal of the NaOAc buffer contained in
the samples. Crosspeak amplitude analysis in the set of 1H-15N HSQC
spectra acquired at KCl titration of the NTII/liposome samples was per-
formed with the Mathematica program (Wolfram Research, Champaign, IL).
Molecular-dynamics simulation of NTII/membrane
interaction
The molecular dynamics (MD) of the system containing NTII (Protein Data
Bank entry 1NOR) and hydrated explicit lipid bilayer of 128 DOPS mole-
cules was simulated using the GROMOS96 force field and GROMACS soft-
ware (24). The construction of the protein/lipid system and the MD protocol
are described in the Supporting Material. Two independent 6-ns MD runs
were performed. In both cases, the molecule of NTII was initially placed
at ~5 A˚ (~15 A˚ for toxin center of mass) above the membrane surface
(defined as the average position of the phosphorous atoms of lipids in the
nearest monolayer). Furthermore, the starting system configurations had
different NTII orientations, with the head region of NTII positioned close
to the membrane (see Fig. 2 C).
RESULTS
NTII binds strongly to the lipid bilayer mimicking
the nAChR membrane environment
Native nAChR membranes are composed of phospholipids
(~70%) with zwitterionic (mainly phosphatidylcholine and
phosphatidylethanolamine) and anionic (mainly phosphati-
dylserine, as well as phosphatidylinositol, cardiolipin, and
phosphatidic acid) headgroups, and cholesterol (~20%).
The fraction of anionic phospholipids varies from ~25% on
average for native nAChR membranes up to ~45% for
nAChR-vicinal lipids (12,25). Experiments with nAChR
embedded in model lipid membranes have shown that the
functional conformations of nAChR and their changes
upon ligand binding are quite sensitive to the membrane
composition, i.e., to cholesterol, phosphatidylserine, and
some zwitterionic phospholipids such as phosphatidylcho-
line and phosphatidylethanolamine (11,12,14). In particular,
nAChR retains functional activity in a model lipid bilayer
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cholesterol with a molar ratio of 3:1:1 (11,14).
Therefore, we chose the membrane composition DOPC/
DOPS/Chol ¼ 3:1:1, which mimics the native-like mem-
brane environment of nAChR, to uncover a possible role
of the cell membrane in receptor/NTII interactions. Prelimi-
nary experiments showed a strong interaction of NTII with
the membrane up to the sample precipitation under low ionic
strength. To determine the lipid/protein molar ratio (L/P)
at which NTII is completely bound to the membrane,
1H-NMR spectra of NTII in aqueous solution were moni-
tored in the presence of an increasing amount of DOPC/
DOPS/Chol liposomes in a liquid-crystalline state. The
increase of lipid concentration resulted in attenuation of
the NMR signal amplitudes of the toxin until their disappear-
ance due to complete binding and immobilization of NTII on
the lipid bilayer at L/P ~40:1 under 30 mMKCl (Fig. 1 A). In
addition, the NTII binding to both pure DOPC and DOPS
membranes was analyzed under the same conditions. It
was found that NTII binds to the anionic DOPS bilayer
(full binding at L/P ~6:1) (Fig. 1 B) but does not bind to
the zwitterionic DOPC bilayer (data not shown).
Finally, it was found that under physiological ionic
strengths of ~150 mM, immobilization of 1 mM NTII was
achieved at lipid concentrations >~140 mM (Fig. S1 A)
and ~70 mM (Fig. S1 B) for anionic lipid fractions of 25%
and 45%, respectively. This effect is a consequence of the
weakening of electrostatic attraction between the cationic
protein and the negatively charged membrane with the
increasing ionic strength. Overall, the anionic lipid fraction,
L/P molar ratio, and ionic strength of the solution shift the
equilibrium of the NTII binding to the lipid bilayer
mimicking the nAChR membrane environment. The effec-
tive lipid concentration in the synaptic cleft is >200 mM,
as estimated from the characteristic synaptic cleft width
(~200 A˚) and mean area per one lipid in the bilayer (~64 A˚2).
Thus, even at physiological ionic strength, most of the toxin
molecules should be bound to the lipid bilayer surrounding
nAChR due to the high fraction of anionic lipids and the
large effective lipid concentration in vivo.
NTII interacts only with the membrane surface and
‘‘captures’’ the headgroup of one DOPS molecule
Protein/membrane interactions may affect the physical
properties of the lipid bilayer and the behavior of its compo-
nents, which can be investigated with the aid of wide-line
31P-NMR spectroscopy. 31P-CSA is sensitive to alterations
in the orientation and motion of lipid headgroups (26–28).
Studies of NTII binding to multilamellar DOPC/DOPS/
Chol and pure anionic DOPS liposomes (Fig. 1, C and D)
revealed changes in 31P-CSA for the portion of DOPS mole-
cules for both membrane compositions. This effect is more
pronounced in the case of pure DOPS membrane, for which
a typical ‘‘bilayer-like’’ 31P-NMR spectrum (Fig. 1 D) with
31P-CSA¼ 50 ppm was observed, whereas the NTII bindingto themembrane leads to the appearance of an additional spec-
tral componentwith reduced 31P-CSA (31 ppm; Fig. 1D). The
integral intensities of this additional component are ~13% and
~7% at a DOPS/NTII molar ratio of 7:1 and 14:1, respec-
tively. This indicates that binding of one NTII molecule
results in changes of orientation and/or motion of the head-
group in one DOPS molecule, which is involved in a specific
interaction with neurotoxin. Unfortunately, in the case of
mixed membrane, the analysis of an additional (NTII-
induced) 31P-spectral component of DOPS was complicated
by its overlapping with the prevailing (75%) signal from
DOPC (Fig. 1 C) and large L/P ratio (40:1).
Due to the diamagnetic anisotropy of phospholipid
molecules, multilamellar liposomes are stretched along the
direction of the applied magnetic field (29) and adopt an
FIGURE 1 NTII binding to lipid bilayers mimicking the nAChR
membrane environment. (A and B) 1H-NMR spectra of 0.3 mM NTII in
the presence of DOPC/DOPS/Chol ¼ 3:1:1 (A) and DOPS (B) liposomes,
30 mM KCl, 10 mM NaPAc, pH 5.5, 303 K. The lipid/protein (L/P) molar
ratio is indicated on the right of each spectrum. Membrane perturbations
upon NTII binding are shown. (C and D) 31P-NMR spectra of a total
26 mM concentration of DOPC/DOPS/Chol ¼ 3:1:1 (C) and 20 mM
DOPS (D) multilamellar liposomes, 30 mM KCl, 10 mM NaPAc, pH 5.5,
303 K without and with membrane-bound NTII. Experimental spectra, theo-
retical approximation, and lineshape decomposition are indicated by gray,
black, and dashed lines, respectively. The parameters of 31P-CSA for
DOPC and DOPS, liposome deformation (c/a) in the magnetic field, and
relative intensities of DOPC and DOPS signals were estimated to be, respec-
tively, (C) without NTII: 395 1 ppm and 515 1 ppm, 1.215 0.05, 75%
and 25%; with NTII: 405 1 ppm and 515 1 ppm, 1.155 0.05, 75% and
25%; (D) without NTII: 505 1 ppm, 1.345 0.05, 100%; and with NTII:
505 1 ppm, 315 1 ppm and 0 ppm (isotropic phase), 1.135 0.05, 86%,
13%, and <1%.Biophysical Journal 97(7) 2089–2097
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ence the membrane properties and alter the extent of lipo-
some deformation in the magnetic field. This effect is
manifested as a redistribution of the intensities between
high- and low-field shoulders in a 31P-NMR spectrum
(19,20). Analysis of the obtained 31P-NMR spectra shows
that NTII binding to the multilamellar DOPC/DOPS/Chol
liposomes (L/P ¼ 40:1) leads to a slight reduction of
the ellipsoid axes ratio (c/a) from 1.21 to 1.15 (Fig. 1 C).
Similarly, NTII binding to a pure anionic DOPS bilayer
(L/P ¼ 7:1) results in a c/a reduction from 1.34 to 1.13
(Fig. 1 D). We previously observed an analogous effect in
cytotoxins, which are structural homologs of a-neurotoxins
from snake venom (19,30). However, in the case of cyto-
toxins, this effect was much greater—up to complete
suppression of the liposome deformation (c/a ¼ 1). Cyto-
toxins interact with lipid membrane, immersing slightly
into its hydrophobic region. This leads to perturbation of
the bilayer packing up to prevailing of nonbilayer lipid phase
giving the isotropic 31P-signal near 0 ppm (26,27) with the
signal intensity of up to 80% at L/P ~12 (19,30), whereas
NTII binding results in a <1% formation of a nonbilayer
(isotropic) lipid phase even at L/P ¼ 7:1 (Fig. 1 D). Thus,
the 31P-NMR data indicate that in contrast to cytotoxins,
NTII does not significantly perturb the lipid bilayer packing,
which is in good agreement with subsequent data indicating
shallow insertion of the toxin into the membrane, no deeper
than the lipid headgroups.
Membrane-binding site of NTII is located
in its ‘‘head’’ region
For a protein bound to a lipid bilayer (such as liposomes), the
values of the rotational correlation time, and thus the NMR
transverse relaxation rate, are much greater than in solution.
Therefore, NMR signals of the NTII molecule in its
membrane-bound state are broadened beyond detection.
Nevertheless, it has been theoretically and experimentally
shown that under certain conditions of slow and intermediate
(on theNMR timescale) exchange between the free and bound
states, the NMR spectra of a free-state protein are highly
sensitive to chemical shift perturbations upon binding (so-
called ‘‘differential line-broadening’’, e.g., as manifested in
the differential reduction of crosspeak amplitudes in 1H-15N
HSQC spectra; see the Supporting Material) (31,32). To
employ this ‘‘differential amplitude reduction’’ technique,
we chose the experimental conditions so as to obtain an appre-
ciable exchange rate and free/bound state ratio, aswell as to be
appropriate for high-resolution NMR spectroscopy (0.4 mM
NTII, lipid/NTII ¼ 40:1 and ~70 mM KCl).
The crosspeak amplitudes in the 1H-15N HSQC spectra of
the 15N-labeled NTII were monitored in the presence of
monolamellar DOPC/DOPS/Chol liposomes as a function
of KCl concentration. The results revealed a sigmoid-like
growth of 1H15N crosspeak amplitudes as a function of
increasing salt concentration (Fig. 2 A). In the 30–120 mMBiophysical Journal 97(7) 2089–2097range of KCl concentration, the toxin undergoes an appre-
ciable exchange between free and membrane-bound states
(an example of HSQC spectra is presented in Fig. S5 B).
The 1H15N crosspeak amplitude growth reached a plateau
at KCl concentrations exceeding ~200 mM KCl, indicating
the disappearance of the membrane-bound state. Of impor-
tance, the detailed analysis of the relative 1H15N amplitudes
growing near the flex point of the titration curve observed in
three independent experiments permits subdivision of the
NTII residues into two distinct groups (Fig. 2 A). It should
be noted that the amplitude dispersion inside both groups
coincides with the overall dispersion of 1H15N crosspeak
amplitudes during salt titration of the NTII sample without
membranes (see Fig. S7). The minor group (Glu-2, Cys-3,
Gln-6, Cys-17, Asn-22, Gly-41, Asn-50, and Arg-58 resi-
dues; Fig. 2 F) with decreased 1H15N crosspeak amplitudes
(Fig. 2 B) consists of amino acid residues whose 1H15N
chemical shifts undergo the greatest change upon NTII
binding to the lipid bilayer.
The chemical shift changes could be a result of either a
specific interaction of lipid molecules with their correspond-
ing NH groups, or their chemical-shift hypersensitivity to
environment perturbations upon NTII binding to the anionic
bilayer. We investigated the latter possibility in several
experiments by considering the ‘‘hypersensitivity’’ of chem-
ical shifts of NTII 1H15N crosspeaks to pH, dielectric
constant, or KCl concentration (see the Supporting Material).
These additional considerations did not reveal a prominent
sensitivity of NH groups of Glu-2, Cys-3, Gln-6, Cys-17,
Asn-22, Gly-41, and Arg-58 residues, whereas NH groups
of Asn-50 showed a chemical-shift hypersensitivity to
dielectric constant changes of the media. Therefore, Asn-
50 cannot serve as an unambiguous probe of the NTII
topology on the membrane. In turn, the spatial localization
of Glu-2, Cys-3, Gln-6, Cys-17, Asn-22, Gly-41, and Arg-
58 residues in the disulfide-rich ‘‘head’’ region of NTII obvi-
ously maps the membrane-binding site on the toxin surface
(Fig. 2 C), which retains its overall structure upon binding
(see the Supporting Material). Of importance, the mapped
membrane-binding site is remote from the receptor inhibition
site located on the tip of the central loop II of NTII, being at
a distance up to 40 A˚ as estimated for side-chain atoms, and
implying an independence of the membrane- and receptor-
binding sites for NTII.
MD simulations of NTII on the water-lipid interface
decipher its membrane-bound topology
To obtain additional insights into the details of NTII/
membrane interaction, we conducted anMD simulation study
using an explicitly hydrated lipid bilayer. In both 6-ns MD
runs, the toxin spontaneously moved closer to the bilayer
surface and interactedwith lipid headgroups. The time-depen-
dent disposition of the NTII molecule on the membrane was
quite variable. Nevertheless, a specific and stable interaction
between NTII and the membrane was observed in one of the
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of NTII interaction with the native-like
nAChR membrane. (A and D) KCl
concentration dependence of the cross-
peak amplitudes in the 1H-15N HSQC
spectra of 0.4 mM NTII and double
mutant NTIIE2Q/D57N in the presence
of monolamellar DOPC/DOPS/Chol ¼
3:1:1 liposomes, L/P ¼ 40:1. The
amplitudes of the 1H15N crosspeaks
were normalized to the corresponding
amplitudes at 200 and 240 mM KSl
when NTII and NTIIE2Q/D57N, respec-
tively, were in the unbound state. The
experimental sigmoid-like dependences
averaged over residues without and with
differential amplitude reduction are
shown by boxes linked by gray lines
and asterisks linked by black lines,
respectively. (Inset) The behavior of
all 1H15N crosspeak amplitudes near
the flex point of titration curve is shown.
Two groups of curves without (total
mass) and with (eight curves) differen-
tial amplitude reduction are denoted as
in the main panel. (B and E) The
1H15N crosspeak amplitudes of NTII
and NTIIE2Q/D57N were averaged over the 72–82 mM and 120–150 mM KCl range, respectively, and plotted against the residue number. The eight residues
(Glu-2, Cys-3, Gln-6, Cys-17, Asn-22, Gly-41, Asn-50, and Arg-58) marked by asterisks clearly demonstrate differential amplitude reduction in the case of
NTII; however, no pronounced differential amplitude reduction was observed for the NTIIE2Q/D57N mutant. (C) Localization of the backbone HN groups of
Glu-2, Cys-3, Gln-6, Cys-17, Asn-22, Gly-41, Asn-50, and Arg-58 (highlighted by black balls) in the NTII spatial structure presented by the ribbon diagram.
The ‘‘fingers’’ of the toxin molecule are indicated by roman numerals. The mapped membrane-binding site and nAChR inhibition site are enclosed by dotted
ovals. (F) The amino acid sequence of NTII. The residues that demonstrate differential amplitude reduction are highlighted in boldface. The residue numbers
and amino acid substitutions are shown above the sequences. S-S bonds are displayed in black lines below the sequence.simulations, which allowed identification of a particular
topology of NTII molecule on the membrane. During the first
ns ofMD, the toxin approached the bilayer surface and finally
settled in the lipid headgroup region, as shown in Fig. 3 A.
This specific topology was retained during the remaining
5 ns of the simulation time. Analysis of the MD trajectories
revealed that NTII formed the most stable contacts with
a single DOPS molecule—its polar headgroup interacts
with the charged side chains of Glu-2, Asp-57, and Arg-58,
which are located exactly in the NTII membrane-binding
site described above. The surface of the site possesses partic-
ular electrostatic properties (Fig. 3C), i.e., there are regions of
high negative and positive electrostatic potentials placed
close to each other. Thus, the negatively charged phosphate
and carboxyl groups of the DOPS molecule interact with
the positively charged guanidine group of Arg-58, forming
one to three hydrogen bonds, whereas the positively charged
amino group of DOPS interacts with the carboxyl groups of
Glu-2 and Asp-57, forming two hydrogen bonds (Fig. 3 B
and Fig. S8). Two additional DOPS molecules that interacted
occasionally with side chains of Glu-2, Thr-14, Thr-16, and
Ser-18 were also identified (Fig. S9). To sum up, a variable
network of intermolecular hydrogen bonds that forms upon
the peripheral membrane binding of NTII constrains the
orientational freedom of the toxin molecule (30 < a < 60,as denoted in Fig. 3 A), thus providing a specific but movable
topology of the toxin on the membrane surface. Therefore,
NTII/membrane interactions are flexible but not strong, in
accordance with the sensitivity of the binding to ionic
strength.
It should be mentioned that such an NTII topology on a
lipid bilayer (Fig. 3 A) agrees well with experimental NMR
data that map the membrane-binding site of NTII in its
‘‘head’’ region (Fig. 2 C). Also, for the most dense packing
of NTII on the DOPS bilayer (at L/P ¼ 6:1; Fig. 1 B), one of
two possible orientations of NTII coincides with its orienta-
tion in MD (Fig. 3 A). Indeed, the maximal occupied area of
the NTII molecule on a plane is ~860 A˚2 (in the loop plane)
and the minimal one is ~380 A˚2 (perpendicular to the loop II
direction). The area of six DOPS molecules on a lipid bilayer
is ~390 A˚2 (33); thus, the NTII molecule participating in
saturating binding to a pure DOPS bilayer (as shown in the
previous section) should be positioned with its loop II
directed close to the bilayer normal (as in Fig. 3 A).
Mutations in the NTII head region eliminate
the speciﬁc toxin-membrane interaction
To confirm the importance of the toxin head region in the
membrane binding, we substituted the identified NTII
residues that participated during the MD simulation inBiophysical Journal 97(7) 2089–2097
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engineered a double Glu-2Gln/Asp-57Asn-mutant of NTII
(NTIIE2Q/D57N) for more effective elimination of hydrogen
bonding with the DOPS lipid headgroups. CD and NMR
spectra demonstrated that the folding was successful and
the native toxin structure was preserved for NTIIE2Q/D57N
(Fig. S2 B and Fig. S4). We then studied the binding of
the uniformly 15N-labeled NTIIE2Q/D57N to the bilayer
mimicking the nAChR membrane by NMR.
In a manner similar to that used for wild-type NTII, we
monitored the crosspeak amplitudes in the 1H-15N HSQC
spectra of NTIIE2Q/D57N in the presence of monolamellar
DOPC/DOPS/Chol liposomes at L/P ¼ 40:1 as a function
of KCl concentration (Fig. 2 D). In the ~80–220 mM range
of KCl, the toxin undergoes an appreciable exchange
between free and membrane-bound states, and the complete
release of NTIIE2Q/D57N from the liposome surface was
FIGURE 3 Topology of NTII on the membrane surface. (A) MDmodel of
NTII association with an explicit DOPS bilayer. The angle a between the
central loop of NTII (vector Thr-21 Ca –His-31 Ca) and the membrane
normal is shown. The distance between phosphorus atoms (magenta balls)
of lipids and the top tip of the toxin loop II (nAChR inhibition site) is de-
noted by the blue arrow. (B) ‘‘Capture’’ of the lipid phosphatidylserine head-
group by the side chains of Glu-2, Asp-57, and Arg-58 from the NTII
membrane-binding site. The toxin side chains and lipid molecule are shown
in stick representation. The carbon, nitrogen, proton, oxygen, and phos-
phorus atoms of the toxin and lipid are colored in green, blue, white, red,
and magenta, respectively. Intermolecular hydrogen bonds are indicated
by dotted lines. The bilayer interface (average position of lipid headgroup
phosphorus atoms) is depicted by the dashed line. (C) Electrostatic interac-
tion of negatively charged phosphate and dipolar serine groups of DOPS
with the NTII membrane-binding site, which is colored according to the
surface electrostatic potential calculated using the DelPhi program (41).Biophysical Journal 97(7) 2089–2097achieved at ~240 mM KCl. The corresponding KCl concen-
trations were larger for NTIIE2Q/D57N than for the native NTII
due to the extra charge of þ2 for the double mutant and
hence the stronger electrostatic attraction of the mutant toxin
molecule to the negatively charged membrane surface. In
contrast to NTII, a detailed analysis of the crosspeak ampli-
tudes near the flex point of the titration curve (~150 mM
KCl) did not reveal a differential amplitude reduction and
consequent selective chemical shift perturbations upon
NTIIE2Q/D57N membrane binding (Fig. 2 E). Also, binding
of NTIIE2Q/D57N to DOPC/DOPS/Chol and DOPS liposomes
did not result in changes of 31P-CSA for DOPS molecules
(data not shown), revealing the absence of specific interac-
tions of NTIIE2Q/D57N with DOPS molecules. Together, these
findings imply the absence of a specific membrane-binding
site for the NTIIE2Q/D57N molecule, and hence the absence
of a preferable orientation on the membrane. Note that our
modeling and experimental (both NMR and mutagenesis)
data correlate well in revealing a specific interaction of the
NTII head region primarily with one DOPS molecule.
DISCUSSION
Speciﬁc interaction of NTII with the membrane
surface can facilitate its receptor search
and recognition
Using heteronuclear NMR and molecular modeling sup-
ported by mutagenesis, we showed that short-chain a-neuro-
toxin NTII binds by its head region to the lipid bilayer
mimicking the nAChR membrane environment (Fig. 2 C)
without insertion into the hydrophobic core of the bilayer.
The charged and hydrophilic side chains of NTII residues
in the mapped membrane-binding site participate in forma-
tion of a labile net of hydrogen bonds with polar lipid head-
groups, resulting in distinctive positioning of the toxin mole-
cule relative to the membrane surface (Figs. 2 C and 3).
In this orientation, the tip of the toxin loop II, which is
responsible for nAChR inhibition, can be raised up to
30–35 A˚ (distance for backbone atoms) above the lipid head-
group region (Fig. 3 A). This is quite favorable for the attack
of the receptor from the membrane-facing periphery, since
the nAChR ligand-binding pocket locates no more than
~40 A˚ away from the membrane interface (1,12,18,34).
Moreover, the peripheral membrane binding allows the toxin
molecule to be sufficiently motile (Fig. 3 A) to be properly
recognized by nAChR.
According to the so-called ‘‘membrane catalysis’’ concept
(8,9), which is believed to be essential for many ligand/
receptor systems, ligands recognize their targets in
membrane-embedded receptors from the membrane-bound
state, thereby accelerating the ligand search of the receptor
and facilitating ligand docking to the receptor. Intermolec-
ular contacts established during the membrane association
and receptor recognition events can result in subsequent
Neurotoxin II Interaction with Membrane 2095conformational changes in both the ligand and receptor. The
lipid-binding site of the ligand, which determines its
topology on or in the membrane, is called the ‘‘address’’,
and the part that contains residues directly involved in form-
ing contacts to the receptor is identified as the ‘‘message’’.
Often the sites are somewhat remote, and amino acid substi-
tutions in the address region will not seriously affect the
affinity to the receptor.
In the case of NTII, our findings are in agreement with the
key feature of the ‘‘membrane catalysis’’ mechanism, namely,
that themembrane promotes ligand accumulation in amovable
optimized topology on themembrane surface favoring ligand-
receptor recognition. Hence, the membrane binding can be
considered as an initial event preceding nAChR recognition
by NTII. According to the membrane-catalysis concept as
applied to NTII action at nAChR, the positively charged toxin
molecules are initially accumulated above or on themembrane
surface due to its electrostatic potential (Fig. 4, step A/B).
The immediate increase in the NTII concentration above the
membrane is regulated by the content of negatively charged
phospholipids in the lipid bilayer and the ionic strength of
the solution. The subsequent specific binding of NTII to the
lipids provides positioning of NTII on the lipid bilayer
(Fig. 4, step B/C) in a location suitable for attack of the
receptor (as discussed in detail above). Finally, the positioned
NTII molecule diffuses laterally in the lipid-bound state to
nAChR (Fig. 4, step C/nAChR), which may be advanta-
geous depending on several different factors (8), including
the membrane concentrations of the receptors. These steps
can be partially directed and accelerated by an increase in
the fraction of anionic phospholipids in the nAChR-vicinal
lipid bilayer (12,25) and by the ability of nAChR to concen-
trate cations (34,35). Overall, these membrane-binding steps
are rate limiting, and the reaction kinetics could be several
orders of magnitude faster than for the ligand/receptor interac-
tion without accumulation on the membrane (8,36).
The specific interaction of NTII with the membrane
surface apparently gives rise mainly to a kinetic advantage
for nAChR inhibition, but should not significantly influence
the final ligand/receptor complex configuration. Thus, the
membrane serves mainly to deliver the toxin molecule to
nAChR in a proper orientation to facilitate receptor recogni-
tion by the toxin inhibition site located above the membrane
surface on the same level with the nAChR ligand-binding
pocket. This assumption is supported by available literature
data that were obtained for short-chain a-neurotoxins by
means of competitive binding measurements, and demon-
strate that amino acid substitutions in the toxin head region
do not significantly affect the nAChR inhibition activity
(37,38). Moreover, it is conceivable that the toxin would
not interact simultaneously with the membrane and the
receptor in the final NTII/nAChR complex, since the toxin
binding into the receptor ligand-binding pocket is incom-
mensurately stronger than its transitory interactions with
lipid headgroups.A previous low-resolution x-ray study (18) suggested that
a long-chain a-neurotoxin (a-bungarotoxin) in the nAChR-
bound state interacts with the phospholipid headgroups of
the surrounding membrane, presumably by head and side
loop regions of the toxin molecule. Such a configuration is
in agreement with the recently obtained crystal structure of
the extracellular domain of nAChR a1 subunit bound to
a-bungarotoxin (7), as well as with modeling of the binding
mode of a-bungarotoxin to nAChR based on x-ray and NMR
data (1,39). Although long- and short-chain a-neurotoxins
may differ in terms of both membrane- and receptor-binding
topology, these data imply that the short-chain a-neurotoxin
NTII can maintain membrane contacts at least during initial
recognition of the nAChR. It should be noted that earlier
EPR and fluorescence studies mapped the head region of
NTII as an additional site that participates in interaction
with nAChR preparations (40). Also, it is interesting to
note that an endogenous nAChR modulator lynx1, which
adopts the three-fingered toxin fold characteristic of a-neuro-
toxin, has a consensus C-terminal sequence, suggesting its
attachment to the membrane surface via a glycophosphatidy-
linositol-anchor (17).
Speciﬁc membrane binding may be widespread
among the a-neurotoxin family
There are many ‘‘three-finger’’ a-neurotoxins of different
origins that effectively inhibit nAChRs. Most of these neuro-
toxins possess a high positive charge (Fig. S10), which
favors their electrostatic accumulation on the membrane
surrounding nAChR. Therefore, it is reasonable to assume
that membrane recognition could be quite common for
FIGURE 4 Membrane catalysis for the nAChR inhibition pathway of
NTII. Step A/B: unspecific electrostatic adsorption of the positively
charged toxin from solution to the negatively charged surface of a cell
membrane. Step B/C: anchoring of the toxin to the lipid headgroups in
a specific orientation that favors the receptor recognition. Step C/nAChR:
NTII lateral diffusion and subsequent recognition of nAChR. The toxin-
binding site between a- and g-subunits of nAChR is marked by a gray
oval. NTII, nAChR, and lipid bilayer are shown schematically.Biophysical Journal 97(7) 2089–2097
2096 Lesovoy et al.a-neurotoxins. Indeed, a comparison of a number of short-
chain a-neurotoxins (Fig. S10, lines 1–14) shows a high
level of homology for residues in positions 2, 57, and 58,
which participate in specific interactions with the phosphati-
dylserine headgroup (Fig. 3, B and C), and in positions 15
and 20, which also form the electrostatic pattern of the
membrane-binding site. As a result, the phosphatidylserine-
binding motif of the toxins is formed by positively charged
Arg or Lys residues in position 58, and negatively charged
Asp and Glu residues in positions 2 and 57. In some short-
chain a-neurotoxins, a coupled rearrangement of charged
residues in the membrane-binding site occurs (Fig. S10, lines
23–25). Although some toxins reveal a lower level of
homology in the membrane-binding site (Fig. S10, lines
15–22 and 26–30), overall these findings support the idea
that membrane catalysis may contribute to the action of
short-chain a-neurotoxins at nAChR.
Long-chain a-neurotoxins are also cationic proteins, and
it has been proposed that they interact with the membrane
surface in complex with nAChR (18). However, long
a-neurotoxins do not demonstrate a sequence homology
(Fig. S11) with short a-neurotoxins located along the identi-
fied membrane-binding site. Therefore, one can expect
possible membrane interactions of long a-neurotoxins to
differ from those revealed for short ones that (assuming the
membrane-catalysis mechanism is correct) should affect
receptor inhibition kinetics. This means that the specificity
of the interaction of long-chain a-neurotoxins with mem-
branes deserves further study.
CONCLUSIONS
It seems logical to assume that for snake neurotoxins to
evolutionarily achieve a highly specific receptor recognition
system, they had to be able to use the entire range of different
molecular mechanisms available to them. For many mem-
brane receptors, the specific interactions of their ligands
with membrane have been recognized as assisting in ligand
binding (8,9); however, up to now, the role of the lipid envi-
ronment in nAChR inhibition by snake a-neurotoxins has
been disregarded. We have demonstrated a specific interac-
tion of the short-chain a-neurotoxin NTII with nAChR
native-like lipid bilayer via hydrogen bonding with the lipid
headgroups. Such specific binding may facilitate toxin
delivery and its association with the receptor via membrane
catalysis. This is achieved by means of a local toxin concen-
tration increase in themembrane-bound state,with amoveable
topology suitable for receptor recognition that implies proper
toxin orientation and position leveling of the toxin receptor-
binding site relative to the nAChR ligand-binding pocket.
There may be a physiological explanation for the fact that
under physiological conditions the a-neurotoxin binds to the
membrane only at high values of effective anionic lipid
concentration. Specifically, the toxin molecules that are
transported through the blood and lymph vessels, whereBiophysical Journal 97(7) 2089–2097the effective lipid/toxin molar ratio is low, should not adsorb
onto cell membranes; rather, they should interact with the
cell surface in the narrow cleft between the nerve ending
and the muscle fiber, where the effective concentration of the
anionic lipids (in particular, phosphatidylserine) is high. In
other words, the specific toxin-lipid interaction and the
proposed membrane-catalysis mechanism should be acti-
vated only in the vicinity of postsynaptic membrane. Further-
more, the possible influence of the transmembrane potential
on toxin binding to the postsynaptic membrane cannot be
excluded.
Overall, these findings imply that the postsynaptic
membrane is more than just a passive platform for integrating
all participants in a signal transduction process through
nAChR. Therefore, specific membrane properties in the
vicinity of nAChR have to be taken into account in the devel-
opment of actual models of toxin-receptor complexes, and
pharmacologically relevant ligands of the receptors. Indeed,
it was recently observed that local anesthetic actions at
nAChR are sensitive to the lipid environment, in particular
to a negative charge of the membrane surface (10).
Of course, the direct relation between the membrane-
binding properties and biological activity of NTII requires
further research, including a thorough investigation of the
toxin-binding kinetics. We believe that our findings will
stimulate new studies to elucidate the details of the molecular
mechanisms that govern specific nAChR recognition by
a-neurotoxins and other ligands, and particularly the role
of the membrane environment in this process.
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